Diagnosis and management of resistant hypertension: state of the art.

TitreDiagnosis and management of resistant hypertension: state of the art.
Publication TypeJournal Article
Year of Publication2018
AuthorsWei, F-F, Zhang, Z-Y, Huang, Q-F, Staessen, JA
JournalNature reviews. Nephrology
Volume14
Issue7
Pagination428-441
Date Published07/2018
DOI10.1038/s41581-018-0006-6
Type of Articlereview
ISSN1759-507X
Abstract

Resistant hypertension is defined as a lack of ambulatory blood pressure response to optimized medical treatment after exclusion of secondary hypertension in patients who are fully adherent to antihypertensive therapy. Patients with resistant hypertension are at high risk of complications, particularly cardiovascular events, and optimization of medical treatment remains the cornerstone of their management. Such optimization should be based on simple algorithms and include the use of aldosterone antagonists. The available data from clinical trials do not support the use of device-based approaches such as renal denervation, baroreflex activation therapy or arteriovenous anastomosis for the treatment of resistant hypertension in the majority of patients. Therefore, device treatment remains a last-resort for patients with truly resistant hypertension in the context of clinical research in highly skilled tertiary referral centres. Future research should focus on improving understanding of the intrinsic (physiological and psychological factors) and extrinsic (environmental stressors) mechanisms that contribute to a lack of response to blood-pressure-lowering drugs in adherent patients. The use of biomarkers to identify patients with early target organ damage and new technologies, such as renal nerve stimulation, to predict blood pressure responses to renal denervation could aid the selection of patients who might benefit from device therapies.

Alternate URL

http://www.ncbi.nlm.nih.gov/pubmed/29700488?dopt=Abstract

First publication date (online)

04/2018

WOS ID (UT)

000435518600007

Alternate JournalNat Rev Nephrol
Citation Key / SERVAL ID8862
Peer reviewRefereed
PubMed ID29700488

                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | dess.info@unisante.ch

Go to top